The giant's big-selling contraceptive has been approved in Europe to provide up to eight years of pregnancy protection
Ovaprene could become the first FDA-approved monthly, self-administered, hormone-free contraceptive product
A portion of Mommy Matters’ net proceeds will go to the global non-profit Saving Mothers
The menopause support platform Health & Her has found that 80 per cent of women reported at least one trigger of perimenopause symptoms, including stress, caffeine,...
The partnership focuses on helping community disproportionately impacted by racial injustice and health inequities
A US venture firm focusing on early-stage women’s health start-ups has announced an LP investment from Bank of America. Led by general partner, Jessica Karr, Coyote...
A California-based female-led biotech company has launched an online marketplace to support women’s health and product development. Mammogen, a women’s health company specialising in noninvasive precision...
The surrogacy market size exceeded US$4b in 2020 and is expected to rise
Béa aims to offer access to fertility care to thousands of couples struggling to conceive
A New York-based biotech company has announced an additional US$17m in funding to develop therapies for improving women’s reproductive health. Gameto uses its cell engineering platform to...
